SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-Jun-24 4:19 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-24 | Grant | 30,000 | -- | -- | 31% 96.03K to 126.03K | |
08-Jun-23 4:08 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-23 | Grant | 30,000 | -- | -- | 45% 66.03K to 96.03K | |
09-Jun-22 4:58 PM View: | Akebia Therapeutics, Inc. (AKBA) | 08-Jun-22 | Grant | 13,700 | -- | -- | 26% 52.33K to 66.03K | |
03-Jun-21 5:27 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Jun-21 | Grant | 13,700 | -- | -- | 35% 38.63K to 52.33K | |
09-Jun-20 4:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 05-Jun-20 | Grant | 13,700 | -- | -- | 55% 24.93K to 38.63K | |
24-Jun-19 4:31 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 21-Jun-19 | Option Exercise | 6,667 | -- | -- | 6% 112.5K to 119.17K | |
10-Jun-19 4:04 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-19 | Grant | 13,700 | -- | -- | 122% 11.23K to 24.93K | |
13-Dec-18 4:40 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 30,000 | -- | -- | (100%) 30.0K to 0 | |
13-Dec-18 6:44 PM View: | Akebia Therapeutics, Inc. (AKBA) | 12-Dec-18 | Grant | 11,229 | -- | -- | 100% 0 to 11.23K | |
16-Nov-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 15-Nov-18 | Option Exercise | 100,000 | $1.13 | $113,000.00 | 800% 12.5K to 112.5K | |
12-Jul-18 6:01 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 50% 20.0K to 30.0K | |
29-Jun-18 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Jun-18 | Option Exercise | 12,500 | -- | -- | 100% 0 to 12.5K | |
20-Jun-17 4:06 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Jun-17 | Grant | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
27-May-16 5:16 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 26-May-16 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
03-Dec-15 4:42 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-15 | Market Sale (Planned) | 964 | $38.06 | $36,689.20 | (2%) 41.68K to 40.71K | 98% |
09-Oct-15 4:00 PM View: | Acorda Therapeutics, Inc. (ACOR) | 07-Oct-15 | Market Sale (Planned) | 5,700 | $30.24 | $172,359.00 | (12%) 47.38K to 41.68K | 98% |
06-Mar-15 6:30 PM View: | Acorda Therapeutics, Inc. (ACOR) | 04-Mar-15 | Grant | 5,872 | -- | -- | 14% 41.51K to 47.38K | |
03-Dec-14 9:21 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-14 | Market Sale (Planned) | 230 | $35.58 | $8,183.10 | (< 1%) 41.73K to 41.51K | 98% |
09-Oct-14 4:17 PM View: | Acorda Therapeutics, Inc. (ACOR) | 07-Oct-14 | Market Sale (Planned) | 5,700 | $33.10 | $188,660.00 | (12%) 47.44K to 41.73K | 98% |
07-Mar-14 4:22 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Mar-14 | Grant | 1,835 | -- | -- | 4% 45.6K to 47.44K | |
09-Oct-13 3:06 PM View: | Acorda Therapeutics, Inc. (ACOR) | 07-Oct-13 | Grant | 45,600 | -- | -- | 100% 0 to 45.6K | |
25-Feb-09 4:13 PM View: | Indevus Pharmaceuticals Inc. (IDEV) | 24-Feb-09 | Disposition (change in control) | 100,443 | -- | -- | (100%) 100.44K to 0 | |
25-Feb-09 4:13 PM View: | Indevus Pharmaceuticals Inc. (IDEV) | 23-Feb-09 | Option Exercise | 100,443 | -- | -- | 46% 220.53K to 320.98K | |
25-Feb-09 4:13 PM View: | Indevus Pharmaceuticals Inc. (IDEV) | 23-Feb-09 | Disposition (change in control) | 220,535 | -- | -- | (69%) 320.98K to 100.44K | |
29-Sep-08 5:14 PM View: | Indevus Pharmaceuticals Inc. (IDEV) | 25-Sep-08 | Grant | 55,918 | -- | -- | 34% 164.62K to 220.53K | |
01-Nov-07 5:17 PM View: | Indevus Pharmaceuticals Inc. (IDEV) | 30-Oct-07 | Grant | 13,500 | -- | -- | 9% 151.12K to 164.62K | |
09-Mar-06 5:23 PM View: | Indevus Pharmaceuticals Inc. (IDEV) | 07-Mar-06 | Grant | 28,800 | -- | -- | 24% 122.32K to 151.12K | |
02-Oct-03 10:00 PM View: | Indevus Pharmaceuticals Inc. (IDEV) | 30-Sep-03 | Grant | 10,000 | $2.13 | $21,300.00 | 9% 112.32K to 122.32K |